EyeArt Events

On Demand Webinar – Diabetic Retinopathy Screening for the Masses: Is Autonomous AI the Solution?

In this webinar, learn how the new EyeArt® Autonomous AI system is transforming the management of Diabetic Retinopathy (DR):

  • Detection of More than Mild and Vision Threatening DR with the EyeArt Autonomous AI System
  • Results from the EyeArt System Prospective, Multi-Center Pivotal Clinical Trial
  • EyeArt System Gradability in Non-Mydriatic Retinal Screening
  • A University Health System’s Vision in Using AI Technology to Manage Screening and Treatment of DR and Other Eye Diseases


SriniVas R. Sadda, MD
President and CEO – Doheny Eye Institute
Chair of Ophthalmology – UCLA Geffen School of Medicine

Jennifer I. Lim, MD
Vice-Chair , Ophthalmology and Director, Retina Service – University of Illinois at Chicago

Jeffrey D. Henderer, MD
Chair, Department of Ophthalmology – Lewis Katz School of Medicine at Temple University